Skip to content
10-Q

Quarterly Report

ACUTUS MEDICAL, INC.

0001628280-24-047933

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 8, 2024 29.91M sh
Shares Diluted Q3 2024 · Sep 30, 2024 29.8M sh
Shares Diluted Q3 2024 · Sep 30, 2024 29.77M sh
Shares Diluted Q3 2024 · Sep 30, 2023 29.26M sh
Shares Diluted Q3 2024 · Sep 30, 2023 29.02M sh
Stock Repurchased Q3 2024 · Sep 30, 2024 $0
Stock Repurchased restated Q3 2024 · Sep 30, 2023 $35K
Capex Q3 2024 · Sep 30, 2024 $148K
Capex restated Q3 2024 · Sep 30, 2023 $1.19M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$27.6M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$45.11M
Long Term Debt Q3 2024 · Sep 30, 2024 $25.27M
Long Term Debt Q3 2024 · Dec 31, 2023 $32.65M
Short Term Debt Q3 2024 · Sep 30, 2024 $7.08M
Short Term Debt Q3 2024 · Dec 31, 2023 $1.86M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $12.6M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $19.17M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$10.3M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$4.81M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$879K
Stockholders Equity Q3 2024 · Sep 30, 2023 $31.71M
Stockholders Equity Q3 2024 · Jun 30, 2023 $43.74M
Stockholders Equity Q3 2024 · Dec 31, 2022 $75.02M
Current Liabilities Q3 2024 · Sep 30, 2024 $14.67M
Current Liabilities Q3 2024 · Dec 31, 2023 $18.94M
Total Liabilities Q3 2024 · Sep 30, 2024 $42.47M
Total Liabilities Q3 2024 · Dec 31, 2023 $54.84M
Current Assets Q3 2024 · Sep 30, 2024 $27.16M
Current Assets Q3 2024 · Dec 31, 2023 $46.25M
Total Assets Q3 2024 · Sep 30, 2024 $32.17M
Total Assets Q3 2024 · Dec 31, 2023 $53.96M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.19
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.27
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.45
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.65
Eps Basic Q3 2024 · Sep 30, 2024 −$0.19
Eps Basic Q3 2024 · Sep 30, 2024 −$0.27
Eps Basic Q3 2024 · Sep 30, 2023 −$0.45
Eps Basic Q3 2024 · Sep 30, 2023 −$1.65
Sga Expense Q3 2024 · Sep 30, 2024 $2.32M
Sga Expense Q3 2024 · Sep 30, 2024 $7.88M
Sga Expense restated Q3 2024 · Sep 30, 2023 $2.35M
Sga Expense restated Q3 2024 · Sep 30, 2023 $9.5M
Rd Expense Q3 2024 · Sep 30, 2024 $0
Rd Expense Q3 2024 · Sep 30, 2024 $0
Rd Expense restated Q3 2024 · Sep 30, 2023 $896K
Rd Expense restated Q3 2024 · Sep 30, 2023 $2.75M
Net Income Q3 2024 · Sep 30, 2024 −$5.61M
Net Income Q3 2024 · Sep 30, 2024 −$8.14M
Net Income Q3 2024 · Sep 30, 2023 −$13.24M
Net Income Q3 2024 · Sep 30, 2023 −$47.9M
Operating Income Q3 2024 · Sep 30, 2024 $489K
Operating Income Q3 2024 · Sep 30, 2024 $224K
Operating Income restated Q3 2024 · Sep 30, 2023 −$1.69M
Operating Income restated Q3 2024 · Sep 30, 2023 −$9.47M
Gross Profit Q3 2024 · Sep 30, 2024 $372K
Gross Profit Q3 2024 · Sep 30, 2024 $8K
Gross Profit restated Q3 2024 · Sep 30, 2023 −$1.09M
Gross Profit restated Q3 2024 · Sep 30, 2023 −$3.02M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $4.89M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $13.02M
Cost Of Revenue restated Q3 2024 · Sep 30, 2023 $3.15M
Cost Of Revenue restated Q3 2024 · Sep 30, 2023 $7.84M
Revenue Q3 2024 · Sep 30, 2024 $5.27M
Revenue Q3 2024 · Sep 30, 2024 $13.03M
Revenue restated Q3 2024 · Sep 30, 2023 $2.06M
Revenue restated Q3 2024 · Sep 30, 2023 $4.82M